ARCA biopharma, Inc. (ABIO)
NASDAQ: ABIO · IEX Real-Time Price · USD
2.46
-0.07 (-2.77%)
At close: Jun 24, 2022 4:00 PM
2.53
+0.07 (2.85%)
After-hours:
Jun 24, 2022 7:38 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 - 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Selling, General & Admin
|
5.5 | 4.77 | 3.98 | 3.88 | 4.64 | 4.27 | 4.39 | 4.07 | 4.01 | 3.23 | Upgrade
|
|
Research & Development
|
13.83 | 4.99 | 1.83 | 4.24 | 14.08 | 12.35 | 7.06 | 5.63 | 2.93 | 1.09 | Upgrade
|
|
Operating Expenses
|
19.34 | 9.77 | 5.81 | 8.12 | 18.71 | 16.61 | 11.46 | 9.69 | 6.94 | 4.32 | Upgrade
|
|
Operating Income
|
-19.34 | -9.77 | -5.81 | -8.12 | -18.71 | -16.61 | -11.46 | -9.69 | -6.94 | -4.32 | Upgrade
|
|
Interest Expense / Income
|
0 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
|
Other Expense / Income
|
-0.01 | -0.03 | -0.17 | -0.16 | -0.17 | -0.17 | -0.01 | -0.01 | -0.01 | -0 | Upgrade
|
|
Pretax Income
|
-19.32 | -9.75 | -5.65 | -7.96 | -18.55 | -16.44 | -11.45 | -9.69 | -6.94 | -4.32 | Upgrade
|
|
Income Tax
|
0 | -0.01 | -0.17 | -0.03 | -0.06 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
|
Net Income
|
-19.32 | -9.74 | -5.48 | -7.93 | -18.49 | -16.44 | -11.45 | -9.69 | -6.94 | -4.32 | Upgrade
|
|
Preferred Dividends
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.03 | 0 | Upgrade
|
|
Net Income Common
|
-19.32 | -9.74 | -5.48 | -7.93 | -18.49 | -16.44 | -11.45 | -9.69 | -8.97 | -4.32 | Upgrade
|
|
Shares Outstanding (Basic)
|
14 | 5 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | Upgrade
|
|
Shares Outstanding (Diluted)
|
14 | 5 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | Upgrade
|
|
Shares Change
|
195.18% | 256.50% | 71.72% | 32.76% | 15.04% | 44.17% | 114.74% | 137.57% | 288.10% | 32.90% | Upgrade
|
|
EPS (Basic)
|
-1.39 | -2.07 | -4.15 | -10.31 | -31.86 | -32.58 | -32.76 | -59.58 | -131.04 | -244.44 | Upgrade
|
|
EPS (Diluted)
|
-1.39 | -2.07 | -4.15 | -10.31 | -31.86 | -32.58 | -32.76 | -59.58 | -131.04 | -244.44 | Upgrade
|
|
Free Cash Flow Per Share
|
-1.35 | -1.64 | -3.64 | -10.72 | -30.15 | -29.77 | -30.18 | -57.93 | -77.68 | -231.09 | Upgrade
|
|
Effective Tax Rate
|
0.00% | 0.09% | 2.96% | 0.39% | 0.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | Upgrade
|
|
EBITDA
|
-19.23 | -9.65 | -5.55 | -7.93 | -18.19 | -16.12 | -11.23 | -9.61 | -6.91 | -4.27 | Upgrade
|
|
Depreciation & Amortization
|
0.09 | 0.09 | 0.09 | 0.02 | 0.36 | 0.32 | 0.21 | 0.08 | 0.03 | 0.04 | Upgrade
|
|
EBIT
|
-19.32 | -9.74 | -5.64 | -7.96 | -18.55 | -16.44 | -11.44 | -9.69 | -6.94 | -4.32 | Upgrade
|
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).